Patients in psychedelic trials often know if they’re taking the study drug or a placebo. But trial design changes could ...

The error points to a big question for pharma as AI gains autonomy and high-profile failures sharpen safety concerns: What ...

Genetic medicines and more selective small molecules are finally pushing the field toward new mechanisms — and potentially ...

The Danish biotech sharpened its global vaccine ambitions by tapping Tarja Stenvall, a Big Pharma vet, to take the helm.

Basecamp Research just netted $140 million in a series C fundraising round that valued the company at $800 million, according ...

Nimbus Therapeutics’ head of R&D dishes on what’s next in AI-enabled drug discovery, years after Takeda completed its ...

The government has announced pricing agreements with 26 pharma companies. But the deals could stymie other plans to lower the ...

Yale researchers untangled norovirus RNA and Evvy just pulled in $40 million for precision medicine in women's health.

Hear that low rumble in the distance? That’s a locomotive loaded with biosimilars headed straight for Merck & Co.’s flagship cancer med Keytruda, bringing direct competition to where the ...